510(k) · Cleared
ClearedAleutian Ibf System
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
K2m, Inc. · MAX Intervertebral Fusion Device With Bone Graft, Lumbar
Cleared on Apr 3, 2014 as substantially equivalent to K082698 (K2m, Inc., 2009) and 5 other predicates after a 129-day review. Its family tree reaches back 13 generations to 1984. 527 later devices descend from it.
- Decided
- Apr 3, 2014
- Review
- 129 days
- Class
- Class II
- Product code
- MAX
- Recalls
- None
- Predicates
- 6
Its longest line of descent runs back 13 generations to K841189 (1984). 65 ancestors in all. 527 later devices descend from it, 14 citing it directly.
- Root · 13 generations backK841189 Oec/Rezaian Spinal FixatorOrthopedic Equipment Co., Inc. · 1984
- 9 generations between
- 3 generations backK101302 Aleutian Ibf SystemK2m, Inc. · 2010
- 2 generations backK103169 AleuttianK2m, Inc. · 2011
- 1 generation backK130699 Aleutian Spinal SystemK2m, Inc. · 2013
- This deviceK133614 Aleutian Ibf SystemK2m, Inc. · 2014
- Descendant · cites it directly · 459 of its ownK150481 Cascadia Interbody SystemK2m, Inc. · 2015 · Recalled
- Descendant · cites it directly · 315 of its ownK160125 Cascadia Interbody SystemK2m · 2016
- Descendant · 2 generations on · 276 of its ownK163230 NuVasive Modulus XLIF Interbody SystemNu Vasive, Incorporated · 2017
- Descendant · cites it directly · 237 of its ownK143126 Renovis S141 Lumbar Interbody Cage SystemRenovis Surgical Technologies · 2015
- Descendant · 2 generations on · 235 of its ownK151374 NuVasive MLX-Medial Lateral Expandable Lumbar Interbody System…Nu Vasive, Incorporated · 2015
Show all 13 generations
- Root · 13 generations backK841189 Oec/Rezaian Spinal FixatorOrthopedic Equipment Co., Inc. · 1984
- 12 generations backK990148 Stackable Cage SystemDepuy Motech Acromed · 1999
- 11 generations backK003043 Surgical Titanium Mesh SystemDepuyacromed · 2001
- 10 generations backK022793 Tetris Spinal ImplantSignus Medical, LLC · 2003
- 9 generations backK031757 Peek Tetris Spinal ImplantSignus Medical, LLC · 2003
- 8 generations backK041888 Curved Peek Tetris Spinal ImplantSignus Medizintechnik GmbH · 2004
- 7 generations backK042930 Spacevision Cage SystemSpine Vision, Inc. · 2004
- 6 generations backK051454 Aleutian Spacer SystemK2m, LLC · 2005
- 5 generations backK063399 Aleutian Spacer SystemK2m, Inc. · 2007
- 4 generations backK082698 Aleutian Ibf SystemK2m, Inc. · 2009
- 3 generations backK101302 Aleutian Ibf SystemK2m, Inc. · 2010
- 2 generations backK103169 AleuttianK2m, Inc. · 2011
- 1 generation backK130699 Aleutian Spinal SystemK2m, Inc. · 2013
- This deviceK133614 Aleutian Ibf SystemK2m, Inc. · 2014
Showing 5 of 527 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 527 · See all- K150481Cascadia Interbody SystemK2m, Inc. · 2015 · cites it directly459descendants
- K160125Cascadia Interbody SystemK2m · 2016 · cites it directly315descendants
- K163230NuVasive Modulus XLIF Interbody SystemNu Vasive, Incorporated · 2017 · 2 generations on276descendants
- K143126Renovis S141 Lumbar Interbody Cage SystemRenovis Surgical Technologies · 2015 · cites it directly237descendants
- K151374NuVasive MLX-Medial Lateral Expandable Lumbar Interbody System, NuVasive AP Expandable…Nu Vasive, Incorporated · 2015 · 2 generations on235descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −13 | K841189 | Oec/Rezaian Spinal Fixator | Orthopedic Equipment Co., Inc. | 1984 | — |
| −12 | K990148 | Stackable Cage System | Depuy Motech Acromed | 1999 | — |
| −11 | K003043 | Surgical Titanium Mesh System | Depuyacromed | 2001 | — |
| −10 | K022793 | Tetris Spinal Implant | Signus Medical, LLC | 2003 | — |
| −9 | K031757 | Peek Tetris Spinal Implant | Signus Medical, LLC | 2003 | — |
| −8 | K041888 | Curved Peek Tetris Spinal Implant | Signus Medizintechnik GmbH | 2004 | — |
| −7 | K042930 | Spacevision Cage System | Spine Vision, Inc. | 2004 | — |
| −6 | K051454 | Aleutian Spacer System | K2m, LLC | 2005 | — |
| −5 | K063399 | Aleutian Spacer System | K2m, Inc. | 2007 | — |
| −4 | K082698 | Aleutian Ibf System | K2m, Inc. | 2009 | — |
| −3 | K101302 | Aleutian Ibf System | K2m, Inc. | 2010 | — |
| −2 | K103169 | Aleuttian | K2m, Inc. | 2011 | — |
| −1 | K130699 | Aleutian Spinal System | K2m, Inc. | 2013 | — |
| 0 (this device) | K133614 | Aleutian Ibf System | K2m, Inc. | 2014 | — |
| +1 | K150481 | Cascadia Interbody System | K2m, Inc. | 2015 | 3 |
| +1 | K160125 | Cascadia Interbody System | K2m | 2016 | — |
| +2 | K163230 | NuVasive Modulus XLIF Interbody System | Nu Vasive, Incorporated | 2017 | — |
| +1 | K143126 | Renovis S141 Lumbar Interbody Cage System | Renovis Surgical Technologies | 2015 | — |
| +2 | K151374 | NuVasive MLX-Medial Lateral Expandable Lumbar Interbody System, NuVasive AP… | Nu Vasive, Incorporated | 2015 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1996 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 9 | 0 |
| 2002 | 7 | 0 |
| 2003 | 9 | 0 |
| 2004 | 9 | 0 |
| 2005 | 4 | 0 |
| 2007 | 2 | 0 |
| 2008 | 3 | 0 |
| 2009 | 1 | 0 |
| 2010 | 1 | 0 |
| 2011 | 1 | 0 |
| 2012 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2015 | 6 | 0 |
| 2016 | 9 | 0 |
| 2017 | 23 | 0 |
| 2018 | 28 | 0 |
| 2019 | 36 | 0 |
| 2020 | 54 | 0 |
| 2021 | 51 | 0 |
| 2022 | 56 | 0 |
| 2023 | 76 | 0 |
| 2024 | 75 | 0 |
| 2025 | 59 | 0 |
| 2026 | 54 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MAX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new MAX device
- #1 K203714 NuVasive Thoracolumbar Interbody Systems…score 102.5 · 24 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (6)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K082698 | Aleutian Ibf SystemSummary page 2…which demonstrated that the subject Aleutian Spinal System components are substantially equivalent to devices previously cleared in K2M's Aleutian Spinal System (K082698, K101302, K103169, KI 10843, K1 13138, K1 30699). 6. Comparison of the technological characteristics of the device to p… | 2009 |
| * | K101302 | Aleutian Ibf SystemSummary page 2…d that the subject Aleutian Spinal System components are substantially equivalent to devices previously cleared in K2M's Aleutian Spinal System (K082698, K101302, K103169, KI 10843, K1 13138, K1 30699). 6. Comparison of the technological characteristics of the device to predicate and lega… | 2010 |
| * | K103169 | AleuttianSummary page 2…e subject Aleutian Spinal System components are substantially equivalent to devices previously cleared in K2M's Aleutian Spinal System (K082698, K101302, K103169, KI 10843, K1 13138, K1 30699). 6. Comparison of the technological characteristics of the device to predicate and legally marke… | 2011 |
| * | K110843 | Aleutian Spacer System | 2011 |
| * | K113138 | Aleutian SystemSummary page 2…Spinal System components are substantially equivalent to devices previously cleared in K2M's Aleutian Spinal System (K082698, K101302, K103169, KI 10843, K1 13138, K1 30699). 6. Comparison of the technological characteristics of the device to predicate and legally marketed devices:… | 2012 |
| * | K130699 | Aleutian Spinal SystemSummary page 2…tem components are substantially equivalent to devices previously cleared in K2M's Aleutian Spinal System (K082698, K101302, K103169, KI 10843, K1 13138, K1 30699). 6. Comparison of the technological characteristics of the device to predicate and legally marketed devices: Previous… | 2013 |
What descends from it? (527)
See all 52714 later devices cite it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K150481 | Cascadia Interbody System | 2015 | 459 |
| K160125 | Cascadia Interbody System | 2016 | 315 |
| K143126 | Renovis S141 Lumbar Interbody Cage System | 2015 | 237 |
| K143258 | PLIF STS, TLIF STS, OLIF STS (Spinal Truss System) | 2015 | 211 |
| K172941 | CASCADIA Interbody System | 2018 | 52 |
| K163364 | MOJAVE Expandable Interbody System | 2017 | 25 |
| K142487 | Chesapeake Stabilization System | 2015 | 7 |
| K161485 | Nanovis Intervertebral Body Fusion System and Forticore (R) | 2016 | 5 |
| K182322 | Duo Lumbar Interbody Fusion Device | 2018 | 2 |
| K171893 | Blustone Synergy Lumbar Interbody Fusion System (Basalt, Magma, Obsidian), Blustone… | 2017 | 2 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 30 years and passes through 8 companies; a new generation was cleared every 1.3 years on median.
- 8 of the 65 ancestors have a recall of any class.
- Of its descendants, K150481 (K2m, Inc., 2015) has gone furthest, with 459 descendants of its own.
- 21 other devices also cite its predicate K082698.
How does its category compare?
All MAX devicesMAX Intervertebral Fusion Device With Bone Graft, Lumbar: FDA decisions, review times, recalls and adverse event reports over 20 years. 2014, this device’s year, is highlighted.
FDA decisions per year · MAX
29in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · MAX
85in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · MAX
5in 2025
Class I (1 since 2007) Class II/III not classified
Adverse event reports per year · MAX
811in 2025
MAUDE reports naming product code MAX, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 7 | 86 | 0 | 12 |
| 2008 | 35 | 88 | 2 | 19 |
| 2009 | 31 | 102 | 9 | 90 |
| 2010 | 29 | 137 | 0 | 154 |
| 2011 | 49 | 98 | 3 | 201 |
| 2012 | 48 | 69 | 11 (1) | 327 |
| 2013 | 58 | 102 | 0 | 380 |
| 2014 | 58 | 115 | 3 | 366 |
| 2015 | 53 | 113 | 1 | 524 |
| 2016 | 64 | 124 | 6 | 647 |
| 2017 | 76 | 116 | 1 | 596 |
| 2018 | 64 | 114 | 4 | 616 |
| 2019 | 60 | 131 | 1 | 699 |
| 2020 | 56 | 106 | 0 | 640 |
| 2021 | 53 | 109 | 0 | 622 |
| 2022 | 41 | 95 | 1 | 618 |
| 2023 | 30 | 87 | 0 | 576 |
| 2024 | 38 | 91 | 1 | 729 |
| 2025 | 29 | 85 | 5 | 811 |
| 2026 | 18 | 95 | 0 | — |
What is it indicated for?
When used as a cervical intervertebral body fusion device, the ALEUTIAN implants are indicated for spinal fusion procedures to be used with autogenous bone graft in skeletally mature patients. Cervical IBF implants are intended for use at one level in the cervical spine, from C2 to TI, for the treatment of cervical disc disease (defined as neck pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies). The…
Read the full statement (322 words)
When used as a cervical intervertebral body fusion device, the ALEUTIAN implants are indicated for spinal fusion procedures to be used with autogenous bone graft in skeletally mature patients. Cervical IBF implants are intended for use at one level in the cervical spine, from C2 to TI, for the treatment of cervical disc disease (defined as neck pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies). The cervical device is intended to be used in patients who have had six weeks of non-operative treatment.
When used as a lumbar intervertebral body fusion device, the ALEUTIAN implants are indicated for spinal fusion procedures to be used with autogenous bone graft in skeletally mature patients. The lumbar IBE implants are intended for use at either one level or two contiguous levels in the lumbar spine, from L2 to SI1, for the treatment of degenerative disc disease (DDD) with up to Grade I spondylolisthesis. DDD is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. The lumbar device is intended to be used in patients who have had six months of non-operative treatment.
When used as vertebral body replacement devices the ALEUTIAN implants are indicated for use in the thoracolumbar spine (TI to LS) for partial replacement (i.e., partial vertebrectomy) of a diseased vertebral body, resected or excised for the treatment of tumors or trauma/fracture in order to achieve anterior decompression of the spinal cord and neural tissues, and to restore the height of a collapsed vertebral body. The ALEUTIAN implants are designed to restore the biomechanical integrity of the anterior, middle, and posterior spinal column even in the absence of fusion for a prolonged period.
For all the above indications the ALEUTIAN implants are intended to be used with supplemental internal fixation appropriate for the implanted level, including K2M Pedicle Screw and Hook Systems, and K2M Spinal Plate Systems.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K133614 · printed Nov 6, 2026
Cite this page
510(k) Report. “K133614: Aleutian Ibf System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K133614
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026